H
Harry Vilkman
Researcher at University of Turku
Publications - 24
Citations - 2158
Harry Vilkman is an academic researcher from University of Turku. The author has contributed to research in topics: Dopamine receptor D2 & Dopamine. The author has an hindex of 19, co-authored 24 publications receiving 2084 citations.
Papers
More filters
Journal ArticleDOI
Age-related dopamine D2/D3 receptor loss in extrastriatal regions of the human brain.
Valtteri Kaasinen,Harry Vilkman,Jarmo Hietala,Kjell Någren,Hans Helenius,Hans Olsson,Lars Farde,Juha O. Rinne +7 more
TL;DR: The results indicate that the previously demonstrated age-related decline in striatal dopamine D2 receptors extends to several extrastriatal regions in normal human males, and the rate of D2/3R decline may be faster in the frontal cortex as compared to the temporal and thalamic regions.
Journal ArticleDOI
Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia
Jarmo Hietala,Erkka Syvälahti,Harry Vilkman,K. Vuorio,V. Räkköläinen,Jörgen Bergman,Merja Haaparanta,Olof Solin,Mikko Kuoppamäki,Esa Eronen,Ulla Ruotsalainen,Raimo K. R. Salokangas +11 more
TL;DR: The major finding in this study is that depressive symptoms in neuroleptic-naive first-admission schizophrenia are associated with low presynaptic dopamine function, which appears to be hemisphere-related and may have drug-treatment implications, e.g., in prediction of response to D2 receptor blocking antipsychotic drugs.
Journal ArticleDOI
Sex differences in striatal presynaptic dopamine synthesis capacity in healthy subjects
Aki Laakso,Harry Vilkman,J.örgen Bergman,Merja Haaparanta,Olof Solin,Erkka Syvälahti,Raimo K. R. Salokangas,Jarmo Hietala +7 more
TL;DR: Women had significantly higher striatal [(18)F]fluorodopa uptake (Ki values) than men and this finding may be associated with sex differences in vulnerability and clinical course of neuropsychiatric disorders with dopaminergic dysregulation, e.g., schizophrenia, alcohol dependence, and Parkinson's disease.
Journal ArticleDOI
High levels of dopamine activity in the basal ganglia of cigarette smokers
Raimo K. R. Salokangas,Harry Vilkman,Tuula Ilonen,Tero Taiminen,J. Bergman,Merja Haaparanta,Olof Solin,A. Alanen,Erkka Syvälahti,Jarmo Hietala +9 more
TL;DR: Smoking is related to greater dopamine activity in the human basal ganglia and nicotine-induced dopamine activity may be a relevant mechanism in dependence on cigarette smoking.
Journal ArticleDOI
Striatal Dopamine Transporter Binding in Neuroleptic-Naive Patients With Schizophrenia Studied With Positron Emission Tomography
Aki Laakso,Harry Vilkman,Birgitta Alakare,Merja Haaparanta,Jörgen Bergman,Olof Solin,Jari Peurasaari,V. Räkköläinen,Erkka Syvälahti,Jarmo Hietala +9 more
TL;DR: Average striatal dopamine transporter density is unaltered in neuroleptic-naive patients with schizophrenia, however, patients lack asymmetry in caudate dopamine transporter binding, which conforms with disrupted brain lateralization in this disorder.